Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2020

01-12-2020 | Affective Disorder | Study protocol

Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial

Authors: Frederike Lunkenheimer, Matthias Domhardt, Agnes Geirhos, Reinhold Kilian, Annabel S. Mueller-Stierlin, Reinhard W. Holl, Thomas Meissner, Kirsten Minden, Morten Moshagen, Ramona Ranz, Cedric Sachser, Doris Staab, Petra Warschburger, Harald Baumeister, COACH consortium

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Adolescents and young adults (AYA) with chronic somatic conditions have an increased risk of comorbid depression and anxiety symptoms. Internet- and mobile-based cognitive behavioural therapy (iCBT) might be one possibility to extend the access to evidence-based treatments. Studies suggest that guided iCBT can reduce anxiety and depression symptoms in AYA. However, little is known about the effectiveness of iCBT for AYA with chronic somatic conditions and comorbid symptoms of anxiety and/or depression in routine care. Evidence on the (cost-)effectiveness of iCBT is essential for its implementation in health care.

Objectives and methods

This multicentre two-armed randomized controlled trial (RCT) aims to evaluate the (cost-) effectiveness of guided iCBT (youthCOACHCD) in addition to treatment as usual (TAU) compared to enhanced treatment as usual (TAU+) in AYA aged 12–21 years with one of three chronic somatic conditions (type 1 diabetes, cystic fibrosis, or juvenile idiopathic arthritis). AYA with one of the chronic somatic conditions and elevated symptoms of anxiety or depression (Patient Health Questionnaire [PHQ-9] and/or Generalized Anxiety Disorder [GAD-7] Screener score ≥ 7) will be eligible for inclusion. We will recruit 212 patients (2 × n = 106) in routine care through three German patient registries. Assessments will take place at baseline and at 6 weeks, 3 months, 6 months, and 12 months post-randomization. The primary outcome will be combined depression and anxiety symptom severity as measured with the PHQ Anxiety and Depression Scale. Secondary outcomes will include health-related quality of life, coping strategies, self-efficacy, stress-related personal growth, social support, behavioural activation, adjustment and trauma-related symptoms, automatic thoughts, intervention satisfaction, working alliance, and Internet usage. The cost-effectiveness will be determined, and potential moderators and mediators of intervention effects will be explored.

Discussion

iCBT might implicate novel ways to increase the access to evidence-based interventions in this specific population. The distinct focus on effectiveness and cost-effectiveness of youthCOACHCD in patients with chronic somatic conditions, as well as intervention safety, will most likely provide important new insights in the field of paediatric e-mental health. A particular strength of the present study is its implementation directly into routine collaborative health care. As such, this study will provide important insights for health care policy and stakeholders and indicate how iCBT can be integrated into existing health care systems.

Trial registration

German Clinical Trials Register (DRKS), DRKS00017161. Registered on 17 September 2019.
Appendix
Available only for authorised users
Literature
1.
Van Der Lee J, Mokkink L, Grootenhuis M, Heymans H, Offringa M. Definitions and measurement of a systematic review. JAMA. 2007;297(24):2741–51.CrossRefPubMed
2.
3.
Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7(5):450–3.CrossRefPubMed
4.
Luque Ramos A, Hoffmann F, et al. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis. Semin Arthritis Rheum. 2017;47(2):269–75.CrossRefPubMed
5.
Chevreul K, Michel M, Brigham KB, López-Bastida J, Linertová R, Oliva-Moreno J, et al. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe. Eur J Heal Econ HEPAC Heal Econ Prev Care. 2016;17(1):7–18.CrossRef
6.
Kuhlmann A, Schmidt T, Treskova M, López-Bastida J, Linertová R, Oliva-Moreno J, et al. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe. Eur J Health Econ. 2016;17(1):79–87.CrossRefPubMed
7.
Bächle C, Icks A, Straßburger K, Flechtner-Mors M, Hungele A, Beyer P, et al. Direct diabetes-related costs in young patients with early-onset, long-lasting type 1 diabetes. PLoS One. 2013;8(8):e70567.CrossRefPubMedPubMedCentral
8.
Pinquart M, Shen Y. Anxiety in children and adolescents with chronic physical illnesses: a meta-analysis. Acta Paediatr. 2011;100:1069–76.CrossRefPubMed
9.
10.
11.
Janicke DM, Harman JS, Kelleher KJ, Zhang J. The association of psychiatric diagnoses, health service use, and expenditures in children with obesity-related health conditions. J Pediatr Psychol. 2009;34(1):79–88.CrossRefPubMed
12.
De Ridder D, Geenen R, Kuijer R, Van Middendorp H. Review psychological adjustment to chronic disease; 2008. p. 372.
13.
DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy vs. medications for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci. 2009;9(10):788–96.CrossRef
14.
15.
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012;16(2):77–84.CrossRefPubMed
16.
17.
Compton SN, March JS, Brent D, Albano AM, Weersing VR, Curry J. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry. 2004;43(8):930–59.CrossRefPubMed
18.
Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, et al. Cognitive-behavioral therapy for depression in Parkinson’s disease: a randomized, controlled trial. Am J Psychiatry. 2011;168:1066–74.CrossRefPubMedPubMedCentral
19.
20.
Baumeister H, Hutter N. Collaborative care for depression in medically ill patients. Curr Opin Psychiatry. 2012;25(5):405–14.CrossRefPubMed
21.
Hintzpeter B, Klasen F, Schön G, Voss C, Hölling H, Ravens-Sieberer U. Mental health care use among children and adolescents in Germany: results of the longitudinal BELLA study. Eur Child Adolesc Psychiatry. 2015;24(6):705–13.CrossRefPubMed
22.
Chavira DA, Stein MB, Bailey K, Stein MT. Child anxiety in primary care: prevalent but untreated. Depress Anxiety. 2004;20(4):155–64.CrossRefPubMed
23.
Costello EJ, He J, Sampson NA, Kessler RC, Ries MK. Services for adolescents with psychiatric disorders: 12-month data from the National Comorbidity Survey-Adolescent. Psychiatr Serv. 2014;65(3):359–66.CrossRefPubMedPubMedCentral
24.
Paganini S, Teigelkötter W, Buntrock C, Baumeister H. Economic evaluations of internet- and mobile.based interventions for the treatment and prevention of depression: a systematic review. J Affect Disord. 2018;225(1):733–55.CrossRefPubMed
25.
26.
Hedman E, Ljótsson B, Lindefors N. Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness. Expert Rev Pharmacoecon Outcomes Res. 2012;12:745–64.CrossRefPubMed
27.
Hedman E, El Alaoui S, Lindefors N, Andersson E, Rück C, Ghaderi A, et al. Clinical effectiveness and cost-effectiveness of Internet- vs. group-based cognitive behavior therapy for social anxiety disorder: 4-year follow-up of a randomized trial. Behav Res Ther. 2014;59:20–9.CrossRefPubMed
28.
Domhardt M, Geßlein H, von Rezori R, Baumeister H. Internet-and mobile-based interventions for anxiety disorders: a meta-analytic review of intervention components. Depress Anxiety. 2019;36:213–24.CrossRefPubMed
29.
Königbauer J, Letsch J, Doebler P, Ebert D, Baumeister H. Internet- and mobile-based depression interventions for people with diagnosed depression: a systematic review and meta-analysis. J Affect Disord. 2017;223(April):28–40.
30.
31.
Domhardt M, Steubl L, Baumeister H. Internet- and mobile-based interventions for mental and somatic disorders in children and adolescents: a systematic review of meta-analyses. Z Kinder Jugendpsychiatr Psychother. 2020;48:33–46.CrossRefPubMed
32.
33.
Ebert DD, Donkin L, Andersson G, Andrews G, Berger T, Carlbring P, et al. Does Internet-based guided-self-help for depression cause harm? An individual participant data meta-analysis on deterioration rates and its moderators in randomized controlled trials. Psychol Med. 2016;46(13):2679–93.CrossRefPubMedPubMedCentral
34.
Dear BF, Zou JB, Ali S, Lorian CN, Johston L, Sheehan J, et al. Clinical and cost-effectiveness of therapist-guided internet-delivered cognitive behavior therapy for older adults with symptoms of anxiety: a randomized controlled trial. Behav Ther. 2015;46:206–17.CrossRefPubMed
35.
McCombie A, Gearry R, Andrews J, Mikocka-Walus A, Mulder R. Computerised cognitive behavioural therapy for psychological distress in patients with physical illnesses: a systematic review. J Clin Psychol Med Settings. 2015;22(1):20–44.CrossRefPubMed
36.
Farrand P, Woodford J. Effectiveness of cognitive behavioural self-help for the treatment of depression and anxiety in people with long-term physical health conditions: a systematic review and meta-analysis of randomised controlled trials. Ann Behav Med. 2015;49(4):579–93.CrossRefPubMed
37.
38.
Lin J, Paganini S, Sander L, Lüking M, Daniel Ebert D, Buhrman M, et al. Internetbasierte Intervention bei chronischen Schmerzen. Dtsch Arztebl Int. 2017;114(41):681–8.PubMedPubMedCentral
39.
40.
Thabrew H, Stasiak K, Hetrick SE, Wong S, Huss JH, Merry SN. E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions. Cochrane Database Syst Rev. 2018;8:CD012489.PubMed
41.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.CrossRefPubMedPubMedCentral
42.
43.
Proudfoot J, Klein B, Barak A, Carlbring P, Cuijpers P, Lange A, et al. Establishing guidelines for executing and reporting internet intervention research. Cogn Behav Ther. 2011;40:82–97.CrossRefPubMed
44.
Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WSM, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Ann Intern Med. 2013;158(3):200–7.CrossRefPubMedPubMedCentral
45.
46.
Richardson LP, McCauley E, Grossmann DC, McCarty CA, Richards J, Russo JE, Rockhill C, Katon W. Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents. Pediatrics. 2010;126(6):1117–23.CrossRefPubMed
47.
Minden K, Niewerth M, Listing J, Zink A. German Study Group of Pediatric Rheumatologists. Health care provision in pediatric rheumatology in Germany--national rheumatologic database. J Rheumatol. 2002;29(3):622–8.PubMed
48.
Hofer SE, Schwandt A, Holl RW, Austrian/German DPV Initiative. Standardized documentation in pediatric diabetology: experience from Austria and Germany. J Diabetes Sci Technol. 2016;10:1042–9.CrossRefPubMedPubMedCentral
49.
Stern M. The use of a cystic fibrosis patient registry to assess outcomes and improve cystic fibrosis care in Germany. Curr Opin Pulm Med. 2011;17:473–7.PubMed
50.
Kroenke K, Wu J, Yu Z, Bair MJ, Kean J, Stump T, et al. Patient health questionnaire anxiety and depression scale: initial validation in three clinical trials. Psychosom Med. 2016;78(6):716–27.CrossRefPubMedPubMedCentral
51.
52.
Baumeister H, Kraft R, Baumel A, Pryss R, Messner E-M. Persuasive e-health design for behavior change. In: Baumeister H, Montag C, editors. Mobile sensing and digital phenotyping. Berlin: Springer; 2019.CrossRef
53.
54.
55.
56.
57.
Filocamo G, Daví S, Pistorio A, Bertamino M, Puberto N, Lattanzi B, Consolaro A, Mahni-Manzoni S, Galasso R, Varnier GC, Martini A, Ravelli A. Evaluation of 21-numbered circle and 10-cm horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis. J Rheumatol. 2010;37(7):1534–41.CrossRefPubMed
58.
59.
Singh G, Athreya B, Fries JF, Goldschmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37:1761–9.CrossRefPubMed
60.
Petersen C, Schmidt S, Bullinger M. DISABKIDS Group. Brief report: development and pilot testing of a coping questionnaire for children and adolescents with chronic health conditions. J Pediatr Psychol. 2004;29(8):635–40.CrossRefPubMed
61.
Jerusalem M. Persönliche Ressourcen, Vulnerabilität und Stresserleben. Göttingen: Hogrefe; 1990.
62.
Schwarzer R. Optimistische Kompetenzerwartung: zur Erfassung einer personalen Bewältigungsressource. Diagnostica. 1994;40:105–23.
63.
Schumacher J, Klaiberg A, Brähler E. Bevölkerungsrepräsentative Normierung der Skala zur Allgemeinen Selbstwirksamkeitserwartung. Diagnostica. 2001;15(31):1–8.
64.
65.
66.
Schaefer JA, Moos GH. Life crises and personal growth. In: Carpenter BN, editor. Personal coping: theory, research and application. Westport: Praeger; 1992. p. 149–70.
67.
Maercker A, Langner R. Persönliche Reifung (personal growth) durch Belastungen und Traumata: Validierung zweier deutschsprachiger Fragebogenversionen. Diagnostica. 2001;47:153–62.CrossRef
68.
Schulz U, Schwarzer R. Soziale Unterstützung bei der Krankheitsbewältigung: die Berliner Social Support Skalen (BSSS). Diagnostica. 2003;49(2):73–82.CrossRef
69.
Boß L, Lehr D, Reis D, Vis C, Riper H, Berking M, Ebert DD. Reliability and validity of assessing user satisfaction with web-based health interventions. J Med Internet Res. 2016;18(8):e234.CrossRefPubMedPubMedCentral
70.
Wilmers F, Munder T, Leonhart R, Herzog T, Plassmann R. Deutschsprachige Version des Working Alliance Inventory short revised (WAI-SR) – ein schulübergreifendes, ökonomisches und empirisch validiertes Instrument zur Erfassung der therapeutischen Allianz. Klin Diagnostik und Eval. 2008;1(3):343–58.
71.
Munder T, Wilmers F, Leonhart R, Linster HW, Barth J. Working alliance inventory-short revised (WAI-SR): psychometric properties in outpatients and inpatients. Clin Psychol Psychother. 2010;17:231–9.PubMed
72.
Teismann T, Ertle A, Furka N, Willutzki U, Hoyer J. The German version of the Behavioral Activation for Depression Scale (BADS): a psychometric and clinical investigation. Clin Psychol Psychother. 2016;23(3):217–25.CrossRefPubMed
73.
Kanter JW, Mulick PS, Busch AM, Berlin KS, Martell CR. The Behavioral Activation for Depression Scale (BADS): psychometric properties and factor structure. J Psychopathol Behav Assess. 2007;29(3):191–202.CrossRef
74.
Kendall C, Howard BL, Hays RC. Self-referent speech and psychopathology: the balance of positive and negative thinking. Cognit Ther Res. 1989;13:583–98.CrossRef
75.
76.
Szende A, Janssen B, Cabases J. Self-reported population health: an international perspective based on EQ-5D. Dordrecht: Springer Netherlands; 2014.CrossRef
77.
78.
Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875–86.CrossRefPubMedPubMedCentral
79.
Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burström K, Cavrini G, et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010;19(6):887–97.CrossRefPubMedPubMedCentral
80.
Craig BM, Greiner W, Brown DS, Reeve BB. Valuation of child health-related quality of life in the United States. Health Econ. 2016;777(April 2015):768–77.CrossRef
81.
Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, Mckenzie NS. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36(4):545–53.CrossRefPubMed
82.
Costello EJ, Angold A. Scales to assess child and adolescent depression: checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry. 1988;27(6):726–37.CrossRefPubMed
83.
Essau CA, Muris P, Ederer EM. Reliability and validity of the Spence’s Children’s Anxiety Scale and the Screen for Anxiety Related Emotional Disorders in German children. J Behav Ther Exp Psychiatry. 2002;33:1–18.CrossRefPubMed
84.
Birmaher B, Brent D, Chiappetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 1999;38(10):1230–6.CrossRefPubMed
85.
Burleson DW, Birmaher B, Melhem NA, Axelson DA, Michaels SM, Brent DA. Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects. J Child Psychol Psychiatry Allied Discip. 2006;47(9):927–34.CrossRef
86.
Thabrew H, Stasiak K, Bavin LM, Frampton C, Merry S. Validation of the Mood and Feelings Questionnaire (MFQ) and Short Mood and Feelings Questionnaire (SMFQ) in New Zealand help-seeking adolescents. Int J Methods Psychiatr Res. 2018;27(3):e1610.CrossRefPubMedPubMedCentral
87.
88.
Brand M, Laier C, Young KS. Internet addiction: coping styles, expectancies, and treatment implications. Front Psychol. 2014;5(Nov):1–14.
89.
Kühner C, Bürger C, Keller F, Hautzinger M. Reliabilität und validität des revidierten Beck-Depressionsinventars (BDI-II). Befunde aus deutschsprachigen Stichproben. Nervenarzt. 2007;78(6):651–6.CrossRefPubMed
90.
Beecham J, Knapp M. Costing psychiatric services. In: Thornicroft G, editor. Measuring mental health. London: Gaskell; 2001. p. 200–24.
91.
Chisholm D, Knapp MRJ, Knudsen HC, Amaddeo F, Gaite L. Client Socio-Demographic and Service Receipt Inventory - European Version: development of an instrument for international research. Br J Psychiatry. 2000;177(39):28–33.CrossRef
92.
Roick C, Kilian R, Matschinger H, Bernert S, Mori C, Angermeyer MC. Die deutsche Version des Client Sociodemographic and Service Receipt Inventory. Psychatrische Prax. 2001;28(2):84–90.CrossRef
93.
Weschenfelder A-K, Reissner V, Knollmann M, Hebebrand J, Wasem J, Neumann A. Ökonomische Evaluation eines manualbasierten Therapiekonzeptes für psychisch kranke Kinder und Jugendliche mit schulvermeidendem Verhalten. Z Kinder Jugendpsychiatr Psychother. 2018;46(1):47–56.CrossRefPubMed
94.
Glick HA. Economic evaluation in clinical trials. Reprinted. Oxford: Oxford University Press; 2010.
95.
Salize H-J, Kilian R. Gesundheitsökonomie in der Psychiatrie. Stuttgart: Kohlmann; 2010.
96.
Willan AR, Briggs AH. Statistical analysis of cost-effectiveness data. New York: Wiley; 2006.CrossRef
97.
Thokala P, Ochalek J, Leech AA, Tong T. Cost-effectiveness thresholds: the past, the present and the future. Pharmacoeconomics. 2018;36(5):509–22.CrossRefPubMed
98.
Orth B. Die Drogenaffinität Jugendlicher in der Bundesrepublik Deutschland 2015. Teilband Computerspiele und Internet. BZgA-Forschungsbericht. Köln: Bundeszentrale für gesundheitliche Aufklärung; 2017.
99.
100.
Metadata
Title
Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial
Authors
Frederike Lunkenheimer
Matthias Domhardt
Agnes Geirhos
Reinhold Kilian
Annabel S. Mueller-Stierlin
Reinhard W. Holl
Thomas Meissner
Kirsten Minden
Morten Moshagen
Ramona Ranz
Cedric Sachser
Doris Staab
Petra Warschburger
Harald Baumeister
COACH consortium
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-4041-9

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue

Study protocol

Postoperative analgesic effect of acupotomy combined with patient-controlled analgesia in patients undergoing video-assisted thoracoscopic surgery: a study protocol for a randomized controlled trial

Study protocol

Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial)

Research

Reducing sitting at work: process evaluation of the SMArT Work (Stand More At Work) intervention

Study protocol

Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): protocol for a randomised controlled trial

Study protocol

Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study

Update

Update to the FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical analysis plan for the trials and for the individual patient data meta-analysis